Mindset Pharma Selects Treatment-Resistant Depression and End of Life Cancer Angst as Indications for MSP-1014, its NoveHow Will The Data Protection Ruling On Ketamine Impact Psychedelic Novel Drug Development Moving Forward?Mindset Pharma Announces its Next Generation Novel 5-MeO-DMT Psychedelic AnalogsSilo Pharma Advances Psychedelic Patent PortfolioTryp Therapeutics Completes Psychotherapy Training for Phase 2a Study at the University of FloridaMajor Psychedelic Clinical Trial Data Is Right Around The CornerPsychedelic Drug Development Companies Are Leveraging Bolt On MedTech Acquisitions To Create A More Robust Patient Care 7 Psychedelic Clinical Trials Underway That Investors Should Keep On Their RadarNuminus Wellness Closes Q3 2021 With $63.2 Million Cash Position, Lab and Trial Advances, and Strategic Expansion into PSilo Pharma Awarded Notice of Allowance from United States Patent and Trademark Office for Homing Peptide PatentTryp Therapeutics Announces Q3 2021 Financial ResultsKetamine One’s IRP Clinic Using Innovative NeuroCatch Platform to Measure Brain Function in Injured VeteransWake Network, Inc. and the Lieber Institute for Brain Development Announce Research CollaborationTryp Therapeutics Announces Plans for Phase 2a Clinical Trial for Fibromyalgia with the University of MichiganNuminus Wellness Reaches Major Milestone With MAPS Sponsored MDMA StudyNuminus Announces Health Canada Approval of MAPS-Sponsored Open Label Study for MDMA-Assisted Therapy for PTSDPsyence Group and UK Psychedelic CRO Partners to Conduct UK Palliative Care Clinical TrialTryp Therapeutics Partners with the University of Michigan to Evaluate Proprietary FormulationsPsyched Wellness Commences Next Pre-Clinical Study on AME-1Atai Life Sciences Is Setting The Standard For Psychedelic Drug Development

Technical420 Site Search

Returned 11 result(s).

Rritual Announces Successful Completion of Second Full Scale Manufacturing Run and Commencement of Third Full Scale Manufacturing Run in Early April

Rritual Superfoods Inc. (CSE: RSF) (CSE: RSF.WT) is pleased to provide an update on its upcoming US retail launch of its plant-based superfood elixirs. Rritual has successfully completed a second commercial scale manufacturing run which is approximately  50% larger than its initial production run.  Production for early April is scheduled and…

Rritual Announces Successful Launch of US Facing E-Commerce Website and Provides Corporate Update

Rritual Superfoods Inc. ("Rritual" or the "Company") (CSE: RSF) (CSE: RSF.WT) is pleased to provide shareholders with a corporate update outlining the successful launch and implementation of the company's US facing E-commerce website as well as highlight other key corporate milestones such as the ECRM Buyers Choice Award and receiving USDA Organic Certification. Launch…

Rritual Mushrooms Is Pioneering The Future Of Functional Foods

Over the last 20 years, the trend toward eating healthy and organic products has become much more prominent and we expect the trend to become more significant. The trend has played a key role in the growth of the functional food market and we believe that the COVID pandemic has…

CEO Spotlight: David Kerbel of Rritual Mushrooms

Welcome to MushroomStocks.com! Today, we are fortunate to have David Kerbel, CEO of Rritual join us to give some insight and direction into what we see as one of the emerging leaders in the functional mushroom space. Rritual, makes premium plant-based elixir powders in small batches featuring mindfully selected medicinal mushrooms…

CEO Spotlight: Doug Drysdale of Cybin Corp.

Today, we are lucky to have Doug Drysdale - CEO - of Cybin Corp. with us and appreciate you taking the time to educate our readers. Cybin is a leading Life Sciences Company focused on the development of products and protocols in the psychedelic, pharmaceutical and nutraceutical sectors. Congratulations on…

Rritual Mushrooms Is Here to Enhance You Daily “Ritual”

Although 2020 has been a challenging year for the global economy, there have been a few bright spots in the market. One of those is the functional and psychedelic mushroom market and this is a vertical that we are closely following. Consumers across the globe have shown a preference for…

The Multi-Billion Dollar Functional Mushroom Market Is Up For Grabs

One of the most exciting trends of 2020 has been the emergence of the functional mushroom market. This vertical has been generating substantial traction over the last decade and this is a trend that is only getting more significant. According to a report by Research and Markets, the global edible…

Functional Mushroom Products Are Providing Psychedelics Companies With A Quick Path To Revenue

When people first hear about the mushroom market, a majority of people do not take it seriously and write it off as a new fad. Unfortunately, these people could not be more wrong. The mushroom industry encompasses a number of high-growth verticals and this is a trend that is not…

New Wave Holdings Corp to Launch Functional Mushroom Products for the North American Market

NEW WAVE HOLDINGS CORP. (the "Company" or "New Wave Holdings") (CSE: SPOR) (FWB: 0XM2), (OTC:TRMND), is pleased to announce through it's investment in Anahit Therapeutics Ltd. ("Anahit"), it has entered into a manufacturing agreement with Kirkman®, a FDA and GMP certified manufacturer to launch two proprietary functional mushroom products for the North…

New Wave Holdings Is Taking A Multifaceted Approach To Creating Value In The Psychedelic and Functional Mushroom Space

During the last year, there has been a large increase in the number of companies that are focused on the psychedelic sector and this is a trend that is expected to continue. Most of these companies have fascinating stories and we urge our readers to proceed with caution. When it…

Older Posts »

Search Again

The psychedelics sector is starting to take off as smart money begins to position itself across the industry.

Stay updated with all latest updates,upcoming events & much more.
Subscribe
SUBSCRIBE NOW
close-link